 |
Alitretinoin |
|---|---|
| Trade Name | Panretin |
| Orphan Indication | Acute promyelocytic leukemia |
| USA Market Approval | USA |
| USA Designation Date | 1992-04-10 00:00:00 |
| Sponsor | Ligand Pharmaceuticals, Inc.;10275 Science Center Dr.;San Diego, California, 92121 |
Related Access Program